Latest 10-Q quarterly reports
NASDAQ
ERAS
Erasca, INCErasca, Inc. reported its first quarter 2026 financial results, highlighted by a significant in-process R&D expense related to a license expansion, while also disclosing a new intellectual property dispute with Revolution Medicines.
AMEX
INTT
Intest CORPInTest Corporation announced a significant increase in revenue for the first quarter of 2026, driven by strong performance across multiple market segments.
NASDAQ
CEVA
Ceva INCCeva, Inc. announced its first quarter 2026 financial results, reporting an 11% year-over-year increase in total revenues to $27.0 million, driven by a significant rise in licensing and related revenues.
NASDAQ
Elicio Therapeutics reports a decrease in R&D expenses for Q1 2026, alongside an increase in G&A costs, and highlights ongoing concerns about its ability to continue as a going concern.
NYSE
Getty Images Holdings, Inc. reported a modest 1.1% revenue increase for Q1 2026, driven by strong editorial content performance, while navigating ongoing merger discussions with Shutterstock and significant legal proceedings.
NYSE
VAALCO Energy Inc. reported a net loss of $93.8 million for the first quarter of 2026, a significant shift from the prior year's profit, driven by lower revenues and substantial derivative instrument losses.
NASDAQ
BTMD
Biote CORPBiote Corp. reported a significant decrease in revenue and net income for Q1 2026, impacted by a product recall, increased legal expenses, and a shift in revenue streams.
NYSE
Kayne Anderson BDC, Inc. disclosed its Q1 2026 financial performance, highlighting a diverse portfolio of debt and equity investments across various industries.
NASDAQ
Franklin Financial Services Corporation reported a significant increase in net income for the first quarter of 2026, driven by robust net interest income and growth in wealth management fees.
NASDAQ
Rekor Systems Inc. announced its first quarter 2026 financial results, showing a 12% increase in total revenue to $10.3 million, driven by growth across its product lines.
NYSE
FutureFuel Corp. reported a significant revenue increase in Q1 2026 driven by its chemical segment, but also saw a widening net loss due to operational costs and derivative impacts.
NASDAQ
Universal Electronics Inc. reported a 14.4% decrease in net sales for the first quarter of 2026, alongside a reduction in gross margin, driven by unfavorable sales mix and tariff costs.
NASDAQ
Metagenomi Therapeutics, Inc. reported a net loss of $23.1 million for the first quarter of 2026, with a decrease in collaboration revenue and operating expenses.
NASDAQ
Pliant Therapeutics reported a net loss of $20.0 million for the first quarter of 2026, a significant decrease from the prior year's loss of $56.2 million, driven by reduced R&D expenses.
NASDAQ
Sana Biotechnology, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a net loss of $47.2 million and highlighting progress in its cell engineering platforms while acknowledging substantial doubt about its ability to continue as a going concern.
NASDAQ
LIF
Life360, INCLife360, Inc. announced a 38% increase in total revenue for the first quarter of 2026, driven by significant growth in subscription and advertising revenue, despite a decline in hardware sales.
OQB
DXYN
Dixie Group INCThe Dixie Group, Inc. reported a net income of $1.15 million for the first quarter of 2026, a significant improvement from a loss in the prior year, despite ongoing macroeconomic pressures.
NASDAQ
SEPN
Septerna, INCSepterna, Inc. reported its first-quarter 2026 financial results, highlighting progress in its clinical-stage drug development programs and a significant increase in revenue driven by its collaboration with Novo Nordisk.
NASDAQ
ArriVent BioPharma reports a reduced net loss for Q1 2026 compared to the prior year, with significant cash reserves bolstering its clinical-stage operations and drug development pipeline.
NASDAQ
Ramaco Resources reported a wider net loss for Q1 2026, driven by softer metallurgical coal markets and increased SG&A expenses related to rare earth mineral project development.
NASDAQ
Gain Therapeutics reports increased operating expenses in Q1 2026, with a net loss of $5.6 million, and highlights substantial doubt about its ability to continue as a going concern.
NASDAQ
Columbia Financial, Inc. announced its first quarter 2026 results, showing a significant increase in net income driven by higher net interest income and a lower provision for credit losses.
NASDAQ
Rigetti Computing reports a significant 199% year-over-year revenue increase for Q1 2026, driven by strong sales of quantum computing systems, while managing increased R&D investments.
NYSE
Simon Property Group reports increased Q1 2026 earnings driven by acquisitions and improved lease income, with a 5.2% rise in average base minimum rent.
OQB
Fortitude Gold Corporation reported a net loss of $1.6 million for the first quarter of 2026, with sales declining significantly due to lower production volumes.
NASDAQ
Quantum Computing Inc. reported a significant revenue increase in Q1 2026 driven by recent acquisitions, though the company continues to incur operating losses.
NYSE
Sally Beauty Holdings, Inc. announced its financial results for the second quarter of fiscal year 2026, reporting a 2.3% increase in consolidated net sales to $903.4 million.
NASDAQ
Gladstone Land Corporation's Q1 2026 filing reveals a net loss, driven by a decrease in fixed lease payments and increased operating expenses, alongside strategic debt management and equity issuances.
NASDAQ
Lincoln Educational Services Corporation announced a significant revenue increase of 22.5% in Q1 2026, driven by a substantial rise in student enrollment and strategic program expansion.
NASDAQ
VTSI
Virtra, INCVirTra, Inc. reported a significant 51% decrease in net sales for the first quarter of 2026, primarily due to delayed customer acceptance of deliveries and government funding uncertainties.